Associations between a polymorphism in the 11 beta hydroxysteroid dehydrogenase type I gene and body composition

被引:43
作者
Gelernter-Yaniv, L
Feng, N
Sebring, NG
Hochberg, Z
Yanovski, JA
机构
[1] NICHD, Unit Growth & Obes, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA
[2] NICHD, Pediat & Reprod Endocrinol Branch, NIH, Bethesda, MD USA
[3] Meyer Childrens Hosp, Haifa, Israel
关键词
child; 11HSD1; glucocorticoids; cortisol; cortisone; polymorphism; linkage; adiposity; pediatric;
D O I
10.1038/sj.ijo.0802327
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated 11 beta hydroxysteriod dehydrogenase type 1 (11betaHSD-1) sequence variants in 103 healthy overweight (BMI 42 s.d.) and 160 nonoverweight (BMI-2 to +2 SD) children to examine the associations between body composition and 11betaHSD-1 polymorphisms. A total of 4.3% of children were homozygous and 30.0% heterozygous for an adenine insertion in intron 3 (ins4436A). By ANCOVA (adjusting for age, sex, race, and height), BMI-s.d. differed according to ins4436A genotype (P<0.005), with the greatest BMI-SD for ins4436A homozygotes (mean +/-s.d., 3.4+/-73.4, vs heterozygotes, 0.8+/-5.5, or wild-type, 1.8+/-7.5). Homozygotes also had greater waist circumference, waist-to-hip ratio, and insulin resistance indices than heterozygote or wild-type children (all P<0.05), but no significant differences in trunk fat by DXA, or in serum lipids. We conclude an intronic 11betaHSD-1 gene polymorphism is associated with greater body mass, altered body composition, and insulin resistance in children. 11betaHSD-1 may be one of the genes relevant for pediatric-onset obesity and its complications.
引用
收藏
页码:983 / 986
页数:4
相关论文
共 22 条
  • [1] METABOLIC IMPLICATIONS OF BODY-FAT DISTRIBUTION
    BJORNTORP, P
    [J]. DIABETES CARE, 1991, 14 (12) : 1132 - 1143
  • [2] Evidence for at least two major loci influencing human fatness
    Borecki, IB
    Blangero, J
    Rice, T
    Pérusse, L
    Bouchard, C
    Rao, DC
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (03) : 831 - 838
  • [3] Lack of mutations of type 1 11β-hydroxysteroid dehydrogenase gene in patients with abdominal obesity
    Caramelli, E
    Strippoli, P
    Di Giacomi, T
    Tietz, C
    Carinci, P
    Pasquali, R
    [J]. ENDOCRINE RESEARCH, 2001, 27 (1-2) : 47 - 61
  • [4] Familial aggregation of obesity, candidate genes and quantitative trait loci
    Chagnon, YC
    Perusse, L
    Bouchard, C
    [J]. CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (04) : 205 - 211
  • [5] The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes
    Chrousos, GP
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (Suppl 2) : S50 - S55
  • [6] Association studies between microsatellite markers within the gene encoding human 11β-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism
    Draper, N
    Echwald, SM
    Lavery, GG
    Walker, EA
    Fraser, R
    Davies, E
    Sorensen, TIA
    Astrup, A
    Adamski, J
    Hewison, M
    Connell, JM
    Pedersen, O
    Stewart, PM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11) : 4984 - 4990
  • [7] GENETIC INFLUENCES ON ADULT WEIGHT-GAIN AND MAXIMUM BODY-MASS INDEX IN MALE TWINS
    FABSITZ, RR
    SHOLINSKY, P
    CARMELLI, D
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (08) : 711 - 720
  • [8] Cortisol effects on body mass, blood pressure, and cholesterol in the general population
    Fraser, R
    Ingram, MC
    Anderson, NH
    Morrison, C
    Davies, E
    Connell, JMC
    [J]. HYPERTENSION, 1999, 33 (06) : 1364 - 1368
  • [9] Frisancho AR, 1999, ANTHROPOMETRIC STAND, P189
  • [10] Lohman TG, 1988, ANTHROPOMETRIC STAND, P1